| Browse All

COMPASS Pathways plc (CMPS)

Healthcare | Medical Care Facilities | London, United Kingdom | NasdaqGS
6.66 USD
After hours: 6.84 +0.18 (2.703%) ⇧ (April 17, 2026, 7:54 p.m. EDT)

Short-term: ★★★★☆ | Long-term: ★★☆☆☆ | Dividends: ☆☆☆☆☆
Hot Take | April 19, 2026, 1:16 a.m. EDT

COMPASS Pathways is currently experiencing a 'run-up' phase post-decision where speculative capital is heavily fronting up in calls at the 8.0 strike level, targeting a recovery from the 6.0 support zone. While the immediate per-share upside momentum appears strong based on options flow, the fundamental valuation remains perilous with deeply negative P/E and dilutive fundraising events. This is a classic 'story trade' setup where the catalyst (FDA approval) is priced in for short-term liquidity, making the stock a high-risk, high-reward momentum play rather than a value investment.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
MSTL ✓0.127101
AutoETS0.131356
AutoTheta0.131380
AutoARIMA0.131750

Forecast horizon: 45 days | Selected: MSTL

Forecast Reliability
Score 54%
H-stat 2.79
Ljung-Box p 0.000
Jarque-Bera p 0.347
Excess Kurtosis -0.66
Attribute Value
Sector Healthcare
Market Cap 898,589,120
Forward P/E -5.57
Beta 2.02
Website https://compasspathways.com

As of April 19, 2026, 1:16 a.m. EDT: Speculators are overwhelmingly bullish on CMPS, evidenced by an 80% imbalance in Open Interest (OI) on the call side compared to puts across near and medium-term expirations. The call data shows significant positioning at the 8.0 strike (upside target), while put activity is heavily concentrated in-the-money at the 6.0 strike (hedging current price risk). Implied Volatility (IV) for calls is suppressed (~0.9-1.2) relative to puts (~1.7), suggesting traders expect lower downside volatility but potential for larger upside moves to realize profits. The strategy profile suggests gamma scalping and bullish calendar spreads rather than pure directional bets.


Info Dump

Attribute Value
52 Week Change 0.97041416
Address1 33 Broadwick Street
All Time High 61.69
All Time Low 2.25
Ask 6.69
Ask Size 1
Average Analyst Rating 1.4 - Strong Buy
Average Daily Volume10 Day 2,390,320
Average Daily Volume3 Month 3,022,962
Average Volume 3,022,962
Average Volume10Days 2,390,320
Beta 2.018
Bid 6.61
Bid Size 2
Book Value -0.55
City London
Compensation As Of Epoch Date 1,767,139,200
Country United Kingdom
Crypto Tradeable 0
Currency USD
Current Price 6.66
Current Ratio 0.773
Custom Price Alert Confidence HIGH
Date Short Interest 1,774,915,200
Day High 6.95
Day Low 6.55
Display Name COMPASS Pathways
Earnings Call Timestamp End 1,762,261,200
Earnings Call Timestamp Start 1,762,261,200
Earnings Timestamp 1,774,355,400
Earnings Timestamp End 1,778,157,000
Earnings Timestamp Start 1,778,157,000
Ebitda -175,074,000
Ebitda Margins 0.0
Enterprise To Ebitda -4.25
Enterprise Value 744,056,128
Eps Current Year -1.21
Eps Forward -1.195
Eps Trailing Twelve Months -3.08
Esg Populated 0
Exchange NMS
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 6.3765
Fifty Day Average Change 0.28349972
Fifty Day Average Change Percent 0.04446008
Fifty Two Week Change Percent 97.04141
Fifty Two Week High 8.9
Fifty Two Week High Change -2.2399998
Fifty Two Week High Change Percent -0.25168538
Fifty Two Week Low 2.25
Fifty Two Week Low Change 4.41
Fifty Two Week Low Change Percent 1.9599999
Fifty Two Week Range 2.25 - 8.9
Financial Currency USD
First Trade Date Milliseconds 1,600,435,800,000
Float Shares 102,161,397
Forward Eps -1.195
Forward P E -5.573221
Free Cashflow 97,138,624
Full Exchange Name NasdaqGS
Full Time Employees 156
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.0
Has Pre Post Market Data 1
Held Percent Insiders 0.0804
Held Percent Institutions 0.44623002
Implied Shares Outstanding 134,923,295
Industry Medical Care Facilities
Industry Disp Medical Care Facilities
Industry Key medical-care-facilities
Is Earnings Date Estimate 1
Language en-US
Last Fiscal Year End 1,767,139,200
Long Business Summary COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. The company develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. The company was incorporated in 2020 and is headquartered in London, the United Kingdom.
Long Name COMPASS Pathways plc
Market us_market
Market Cap 898,589,120
Market State CLOSED
Max Age 86,400
Message Board Id finmb_576453668
Most Recent Quarter 1,767,139,200
Net Income To Common -287,862,016
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 898,589,144
Number Of Analyst Opinions 12
Open 6.8
Operating Cashflow -157,240,000
Operating Margins 0.0
Payout Ratio 0.0
Phone 44 716 6766461
Post Market Change 0.1800003
Post Market Change Percent 2.7027073
Post Market Price 6.84
Post Market Time 1,776,470,075
Previous Close 6.66
Price Eps Current Year -5.504132
Price Hint 2
Price To Book -12.109091
Profit Margins 0.0
Quick Ratio 0.666
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key strong_buy
Recommendation Mean 1.41667
Region US
Regular Market Change 0.0
Regular Market Change Percent 0.0
Regular Market Day High 6.95
Regular Market Day Low 6.55
Regular Market Day Range 6.55 - 6.95
Regular Market Open 6.8
Regular Market Previous Close 6.66
Regular Market Price 6.66
Regular Market Time 1,776,456,001
Regular Market Volume 1,902,375
Return On Assets -0.51676
Return On Equity -5.65283
Sand P52 Week Change 0.38150132
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Shares Outstanding 134,923,295
Shares Percent Shares Out 0.069
Shares Short 8,892,595
Shares Short Previous Month Date 1,772,150,400
Shares Short Prior Month 6,287,676
Short Name COMPASS Pathways Plc - American
Short Percent Of Float 0.0699
Short Ratio 3.7
Source Interval 15
Symbol CMPS
Target High Price 70.0
Target Low Price 8.0
Target Mean Price 21.75
Target Median Price 18.5
Total Cash 149,608,000
Total Cash Per Share 1.16
Total Debt 35,035,000
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -3.08
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 5.7764
Two Hundred Day Average Change 0.88359976
Two Hundred Day Average Change Percent 0.1529672
Type Disp Equity
Volume 1,902,375
Website https://compasspathways.com
Zip W1F 0DQ